Gall Matthew

Tango Therapeutics, Inc. · Chief Financial Officer

Gall Matthew is listed in public filings as officer: Chief Financial Officer. This Gall Matthew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tango Therapeutics, Inc. (TNGX), Kalaris Therapeutics Inc (KLRS), and iTeos Therapeutics, Inc. (ITOS). Investors use Gall Matthew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
iTeos Therapeutics, Inc.ITOS$39k5k sharesBuyNov 19, 2024$7.73--